HB Wealth Management LLC lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% in the ...

Masimo appointed Katie Szyman as its next chief executive officer and named current interim CEO Michelle Brennan as the new ...

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...

Edwards Lifesciences (NYSE:EW) traded lower in the premarket on Thursday after Wolfe Research downgraded the heart device ...

Masimo (Nasdaq: MASI) + Masimo Corporation $172.4 1.44% Open 173.198 Day High 175.067 52 Week High 147.89 52 Week Low 75.22 announced today that it appointed Katie Szyman as its new CEO, effective Feb ...

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core ...

EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.

Edwards Lifesciences Corp. closed $22.48 below its 52-week high ($96.12), which the company reached on March 28th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bernstein analyst Lee Hambright raised the firm’s price target on Edwards Lifesciences (EW) to $74 from $72 and keeps a Market Perform rating ...

Masimo Corp. today announced Katie Szyman as its new chief executive, effective Feb. 12. Szyman is currently worldwide ...